Last reviewed · How we verify

Nigella Sativa Oil

University of Health Sciences Lahore · FDA-approved active Small molecule

Nigella sativa oil exerts multi-target anti-inflammatory, antioxidant, and immunomodulatory effects through its active constituent thymoquinone and other phytochemicals.

Nigella sativa oil exerts multi-target anti-inflammatory, antioxidant, and immunomodulatory effects through its active constituent thymoquinone and other phytochemicals. Used for Inflammatory and autoimmune conditions (traditional use), Metabolic syndrome and diabetes (investigational), Respiratory and allergic conditions (traditional use).

At a glance

Generic nameNigella Sativa Oil
Also known asBlack seed Oil, Habbatussauda Oil MADINAH, Black seed oil capsule
SponsorUniversity of Health Sciences Lahore
Drug classHerbal extract / botanical supplement
ModalitySmall molecule
Therapeutic areaImmunology, Inflammation, Metabolic disorders
PhaseFDA-approved

Mechanism of action

Nigella sativa (black seed) oil contains thymoquinone and other bioactive compounds that suppress pro-inflammatory cytokines, reduce oxidative stress via free radical scavenging, and modulate immune cell function. The oil has demonstrated effects on NF-κB signaling inhibition and antioxidant enzyme upregulation in preclinical and clinical studies, contributing to its broad therapeutic potential across inflammatory and metabolic conditions.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: